Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects

Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects

Abstract Background The linkage between IDO2 expression and cancer progression is still unclear, particularly in medullary thyroid carcinoma (MTC). Our purpose is to unveil the potential correlations between IDO2 status, clinical-pathological parameters, patients’ prognosis, and the possible immunom...

Full description

Bibliographic Details
Main Authors: Pengfei Gu, Bin Ling, Weike Ma, Jinming Zhang, Wei Zhang, Yu Zeng, Yu Liu, Jiadong Chi, Xianhui Ruan, Xiangqian Zheng, Songfeng Wei, Ming Gao
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Cancer
Online Access:https://doi.org/10.1186/s12885-022-10173-7

Internet

https://doi.org/10.1186/s12885-022-10173-7

Similar Items